000538:SZSEYunnan Baiyao Group Co.,Ltd Analysis
Data as of 2026-07-18 - not real-time
CN¥51.42
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Yunnan Baiyao is trading above its 20‑day (≈48.9) and 50‑day (≈49.6) moving averages but still below the 200‑day benchmark (≈54.6), a pattern the model flags as a short‑term bullish bias within a longer‑term bearish backdrop. The MACD histogram is positive and the signal line is negative, reinforcing the bullish tilt, while the RSI sits in the 62 zone, hinting at modest overbought pressure. Volume has surged, beta is exceptionally low, and 30‑day volatility exceeds 20%, creating a mix of strong momentum and heightened price swings. The market sentiment index reads “Extreme Greed,” suggesting enthusiasm may be outpacing fundamentals.
Fundamentally, the company delivers 7% revenue growth, solid gross (≈29%) and operating margins (≈18%), and a healthy ROE near 13%. Cash on hand dwarfs debt, the dividend yield of 3% is backed by a 40% payout ratio, and the forward PE of roughly 16 compares favorably to an industry average of 29. Analyst consensus targets near 69 CNY, implying upside potential despite the DCF fair value of about 41 CNY, which flags a valuation gap that warrants careful positioning.
Fundamentally, the company delivers 7% revenue growth, solid gross (≈29%) and operating margins (≈18%), and a healthy ROE near 13%. Cash on hand dwarfs debt, the dividend yield of 3% is backed by a 40% payout ratio, and the forward PE of roughly 16 compares favorably to an industry average of 29. Analyst consensus targets near 69 CNY, implying upside potential despite the DCF fair value of about 41 CNY, which flags a valuation gap that warrants careful positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term resistance with overbought RSI
- Positive MACD but long‑term SMA200 still above price
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth and margins outpacing many peers
- Attractive dividend yield with sustainable payout
- Analyst price targets suggest ~30% upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong cash position and low leverage
- Brand heritage and diversified product portfolio
- Low beta indicating limited systematic risk
Key Metrics & Analysis
Financial Health
Revenue Growth7.00%
Profit Margin12.53%
P/E Ratio17.4
ROE12.76%
ROA5.33%
Debt/Equity0.77
P/B Ratio2.2
Op. Cash FlowCN¥4.7B
Free Cash FlowCN¥3.4B
Industry P/E29.0
Technical Analysis
TrendBearish
RSI62.1
SupportCN¥46.29
ResistanceCN¥52.62
MA 20CN¥48.92
MA 50CN¥49.63
MA 200CN¥54.59
MACDBullish
VolumeIncreasing
Fear & Greed Index87.91
Valuation
Fair ValueCN¥41.39
Target PriceCN¥69.15
Upside/Downside34.47%
GradeFair
TypeBlend
Dividend Yield3.08%
Risk Assessment
Beta0.07
Volatility21.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.